Article thumbnail

Dietary cholesterol, female gender and n-3 fatty acid deficiency are more important factors in the development of non-alcoholic fatty liver disease than the saturation index of the fat

By Tine M Comhair, Sonia C Garcia Caraballo, Cornelis HC Dejong, Wouter H Lamers and S Eleonore Köhler
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3045875
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2007). A: A novel peroxisome proliferator-activated receptor responsive elementluciferase reporter mouse reveals gender specificity of peroxisome proliferator-activated receptor activity in liver. Mol Endocrinol
  2. (1996). A: Intestinal lymph absorption of butter, corn oil, cod liver oil, menhaden oil, and eicosapentaenoic and docosahexaenoic acid ethyl esters in rats. Lipids
  3. (2009). AE: Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.
  4. (1999). al: A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids.
  5. (2006). al: Localization of oxidized phosphatidylcholine in nonalcoholic fatty liver disease: impact on disease progression. Hepatology
  6. (2006). An Improved, Single Step Standardized Method of Lipid Extraction from Human Skeletal Muscle Tissue. Analytical Letters
  7. (2007). Assy N: Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats.
  8. (2008). Blaak EE: Impaired skeletal muscle substrate oxidation in glucose-intolerant men improves after weight loss. Obesity (Silver Spring)
  9. (2006). Bollheimer LC: Defining high-fat-diet rat models: metabolic and molecular effects of different fat types.
  10. (2007). Bollheimer LC: High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring)
  11. (1999). BR: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.
  12. (2009). Buurman WA: Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis.
  13. (2008). CC: Dietary polyunsaturated fatty acids (C18:2 omega6 and C18:3 omega3) do not suppress hepatic lipogenesis. Biochim Biophys Acta
  14. (2008). E: Short-term high fat-feeding results in morphological and metabolic adaptations in the skeletal muscle of C57BL/6J mice. Physiol Genomics
  15. (2008). et al: Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology
  16. (2007). et al: Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab
  17. (1992). et al: Progesterone blocks cholesterol translocation from lysosomes.
  18. (2005). Feeding apolipoprotein Eknockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis. Mol Cell Biochem
  19. (2006). Flier JS: TLR4 links innate immunity and fatty acid-induced insulin resistance.
  20. (1998). Gomez Sanz R: Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program. Transplant Proc
  21. (2010). Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology
  22. (2006). Histological assessment of non-alcoholic fatty liver disease. Histopathology
  23. (2006). Hofker MH: Early diet-induced nonalcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates.
  24. (1990). Holman RT: Reduced arachidonate in serum phospholipids and cholesteryl esters associated with vegetarian diets in humans.
  25. (2005). Ikonen E, et al: Liver X receptor activation controls intracellular cholesterol trafficking and esterification in human macrophages. Circ Res
  26. (2000). Khettry U: Steatosis in donor and transplant liver biopsies. Hum Pathol
  27. (2008). Kypreos KE: Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice. Febs J
  28. (2001). Lindros KO: The antiestrogen toremifene protects against alcoholic liver injury in female rats.
  29. (2002). Mechanisms of hepatotoxicity. Toxicol Sci
  30. (2007). MH: Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase.
  31. (2006). Mice fed a lipogenic methionine-cholinedeficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1.
  32. (2002). Modulation of murine liver macrophage clearance of liposomes by diethylstilbestrol. The effect of vesicle surface charge and a role for the complement receptor Mac-1 (CD11b/CD18) of newly recruited macrophages in liposome recognition.
  33. (2009). Moorman AF: Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res
  34. (1998). OF: Steatohepatitis: a tale of two “hits"? Gastroenterology
  35. (2007). Olive oil and the cardiovascular system. Pharmacol Res
  36. (2007). Olive oil preparation determines the atherosclerotic protection in apolipoprotein E knockout mice.
  37. (2006). Pagliassotti MJ: Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology
  38. (2007). Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury.
  39. (2003). Rizzetto M: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology
  40. (2008). Sex- or gender-specific medicine in hepatology. Hepatol Res
  41. (2007). Sibille B: Long term highly saturated fat diet does not induce NASH in Wistar rats. Nutr Metab (Lond)
  42. (1996). Stimulation of the activities of hepatic fatty acid oxidation enzymes by dietary fat rich in alpha-linolenic acid in rats.
  43. (1998). Substantial carbon recycling from linoleate into products of de novo lipogenesis occurs in rat liver even under conditions of extreme dietary linoleate deficiency.
  44. (1998). Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2.
  45. (2005). Verkade HJ: Essential fatty acid deficiency in mice is associated with hepatic steatosis and secretion of large VLDL particles. Am J Physiol Gastrointest Liver Physiol
  46. (2004). Y: Diet-induced changes in stearoyl-CoA desaturase 1 expression in obesity-prone and -resistant mice. Obes Res